|
Invatec has received the FDA’s 510(k) clearance to market its Reef HP, a percutaneous transluminal angioplasty (PTA) balloon catheter, for use in peripheral high pressure dilatation procedures.
Cook Medical has received FDA approval to market its balloon dilatation catheter, the Advance 35LP, which is intended for use in patients with lesions in the femoral, iliac and renal arteries.
Invatec, a provider of interventional products, has entered into a distribution agreement with interventional vascular disease treatment system developer Cardiovascular Systems, which recently merged with the biotech firm Replidyne.
C. R. Bard has received pre-market approval from the FDA to market its LifeStent FlexStar and FlexStar XL vascular stent systems for the treatment of occlusive disease in native superficial femoral arteries and proximal popliteal arteries.
|
Cook Medical is introducing five new products, which seek to treat peripheral arterial disease (PAD) and other diseases of the circulatory system.
Peripheral arterial occlusive disease is becoming an increasingly more common presentation, particularly as the population ages in the industrial world. The utilization of CT angiography (CTA) to visualize and evaluate the extent of the disease can be a more attractive option compared with the current diagnostic standard of digital subtraction angiography, which is an invasive and expensive examination.
The notion that pre-treatment imaging can improve a stroke patient's prognosis has been widely accepted; however, questions remain about which modality to use, according to data presented at the 2009 European Congress of Radiology (ECR) this week in Vienna, Austria.
|
RSS 
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.
There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.
U.S. News & World Report and HealthGrades surveys that rank “Best Hospitals” according to their high-quality cardiovascular care do not create the most comprehensive list and may create confusion by excluding hospitals that provide the same quality of care, according to a study published in the January issue of the Journal of the American College of Surgeons.